Bristol-Myers Squibb 3Q Revenues: $5.1 billion (+22%) 3Q Earnings: $858 million (+154%) YTD Revenues: $14.5 billion (+5%) YTD Earnings: $2.3 billion (+35%) Comments: Earnings for 3Q07 were boosted by $247 million from the sell-off of the Bufferin and Excedrin brands in Japan. Worldwide pharma sales grew 24% to $3.9 billion, but that growth rate is affected by the 3Q06 sales of generic Plavix by Apotex. The company estimated that the generic competitor sapped $525-$600 million from...